Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Total Non-Current Liabilities (2020 - 2025)

Bio Essence has reported Total Non-Current Liabilities over the past 6 years, most recently at $56156.0 for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 87.45% year-over-year to $56156.0; the TTM value through Dec 2025 reached $56156.0, down 87.45%, while the annual FY2025 figure was $56156.0, 87.45% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $56156.0 at Bio Essence, down from $56493.0 in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $3.2 million in Q1 2025 and troughed at $46219.0 in Q4 2023.
  • A 5-year average of $1.2 million and a median of $1.3 million in 2022 define the central range for Total Non-Current Liabilities.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 1453.99% in 2025 and fell as far as 98.16% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $1.4 million in 2021, then fell by 10.47% to $1.2 million in 2022, then tumbled by 96.24% to $46219.0 in 2023, then skyrocketed by 868.03% to $447414.0 in 2024, then crashed by 87.45% to $56156.0 in 2025.
  • Business Quant data shows Total Non-Current Liabilities for BIOE at $56156.0 in Q4 2025, $56493.0 in Q3 2025, and $156344.0 in Q2 2025.